N-Glycosylation of Recombinant Therapeutic Glycoproteins in Plant Systems

Biljana Balen* and Marijana Krsnik-Rasol

Department of Molecular Biology, Faculty of Science, University of Zagreb, Horvatovac 102a, HR-10000 Zagreb, Croatia

Article history:

Received January 25, 2006
Accepted September 21, 2006

Key words:

N-glycosylation, transgenic plants, glycosyltransferases, sialic acid, recombinant protein, therapeutic glycoproteins


Transgenic plants have recently emerged as a promising system for low-cost and large-scale production of therapeutic proteins. Despite many advantages plants offer as hosts for expression of recombinant proteins, there are certain limitations caused by major structural differences between plant and mammalian N-linked glycans. Thus, efforts are being made in order to eliminate, or at least minimize, plant-specific N-glycosylation as well as to supplement the plant endogenous system with human glycosyltransferases to obtain »humanized« non-immunogenic N-glycans on plant-made pharmaceuticals aimed for human therapy.

*Corresponding author: 
                                               ++385 1 46 06 268
                                               ++385 1 46 06 286

Search FTB

Follow us

 facebook 1 twitter bird_icon LI In Bug


Environmental Policy

sdg publishers compact 4 300x300

QR Code


We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our privacy policy.

I accept cookies from this site.

EU Cookie Directive Module Information